L
Laura Maguire
Publications - 5
Citations - 22
Laura Maguire is an academic researcher. The author has contributed to research in topics: Medicine & Risk assessment. The author has an hindex of 1, co-authored 5 publications receiving 1 citations.
Papers
More filters
Journal ArticleDOI
Predicting prognosis in COVID-19 patients using machine learning and readily available clinical data.
Thomas Campbell,Melissa P Wilson,Heinrich Roder,Samantha MaWhinney,Robert W. Georgantas,Laura Maguire,Joanna Roder,Kristine M. Erlandson +7 more
TL;DR: In this paper, the authors developed models to stratify patients by risk of severe outcomes during COVID-19 hospitalization using readily available information at hospital admission, including basic patient characteristics, vital signs at admission, and basic lab results collected at time of presentation.
Journal ArticleDOI
Explaining multivariate molecular diagnostic tests via Shapley values
TL;DR: In this article, the authors calculate and discuss the interpretation of exact Shapley values for a multivariate molecular diagnostic test in clinical use (the VeriStrat® test), and employ some standard approximation techniques for Shapley value computation (local interpretable model-agnostic explanation (LIME) and Shapley Additive Explanations (SHAP) based methods) and compare the results with exact ShapLEY values.
Posted ContentDOI
Predicting Prognosis in COVID-19 Patients using Machine Learning and Readily Available Clinical Data
Thomas Campbell,Melissa P Wilson,Heinrich Roder,Samantha MaWhinney,Robert W. Georgantas,Laura Maguire,Joanna Roder,Kristine M. Erlandson +7 more
TL;DR: In this article, the authors developed models to stratify patients by risk of severe outcomes during COVID-19 hospitalization using readily available information at hospital admission, including basic patient characteristics, vital signs at admission, and basic lab results collected at time of presentation.
Journal ArticleDOI
28 Predictions of outcomes and benefit of immune checkpoint inhibitor treatment in NSCLC require information on both tumor and host biology
Joanna Roder,Thomas Campbell,Senait Asmellash,Steven Rightmyer,Patrick Norman,Robert W. Georgantas,Mark McCleland,Wei Zou,Minu K. Srivastava,Lelia Net,Laura Maguire,Heinrich Roder,David S. Shames +12 more
TL;DR: Kowanetz et al. as discussed by the authors applied the anti-PD-L1 Response Test (ART) to the larger OAK NSCLC Ph3 clinical study to investigate the interplay between tumor PDL1 expression and ART classifications in predicting outcomes and benefit from A therapy.
Patent
Predictive test for identification of early stage nsclc patients at high risk of recurrence after surgery
TL;DR: In this paper, a method for predicting whether an early stage (IA, IB) non-small-cell lung cancer (NSCLC) patient is at a high risk of recurrence of the cancer following surgery involves subjecting a blood-based sample from the patient (obtained prior to, at, or after the surgery) to mass spectrometry and classification with a computer implementing a classifier.